While antibody mediated hyper-acute vasculitic rejection is rare in liver transplant recipients,
acute and chronic rejection have clinical significance. The liver allograft behaves differently …

Liver transplantation is the most successful treatment for limited-stage HCC. The waiting
time for liver transplantation (LT) can be a critical factor affecting the oncological prognosis …

Omics data address key issues in liver transplantation (LT) as the most effective therapeutic
means for end-stage liver disease. The purpose of this study was to review the current …

Die Lebertransplantation stellt häufig eine lebensrettende Therapieoption eines akuten oder
chronischen Funktionsausfalls der Leber dar und zählt nach der Niere zu den …

Living donors are healthy individuals who are exposed to a major surgical procedure during
which a major part of their liver is resected. Data on the long‐term consequences of living …

Introduction. The possible risk factors for chronic kidney disease in transplant recipients
have not been thoroughly investigated after living‐donor liver transplantation. Material and …

Metabolic liver diseases (MLDs) are a heterogeneous group of inherited conditions for
which liver transplantation can provide definitive treatment. The limited availability of …

Abstract Changes in recipient and donor characteristics are redefining the role of induction
in liver transplant recipients. Older recipients are more common, with greater concomitant …

Liver transplantation (LT) represents a life-saving surgical procedure and is considered the
current standard of care for the majority of patients having end-stage liver disease. As …

Background Living donor liver transplantation (LDLT) is considered a safe alternative to
deceased donor liver transplantation (DDLT). In Egypt, DDLT program is still awaited …